RAHWAY, N.J. — Merck on Tuesday announced late-breaking results from three Phase 3 clinical trials evaluating its investigational, once-daily, two-drug regimen doravirine/islatravir (DOR/ISL) for...
CAMBRIDGE, Mass. — Researchers, patient advocates, biotechnology executives, and state policymakers will gather on Wednesday, February 25, 2026, from 10:00 a.m. to 2:00 p.m....
WALTHAM, Mass. — Trinity has been ranked among the world’s leading health sciences consulting firms in the 2026 Vault Consulting Rankings, earning recognition in...
CAMBRIDGE, Mass. — Prime Coalition and Rho Impact said they have expanded their partnership to provide free access to investor-grade climate impact data, making...
ORANGE, Conn. — The Avangrid Foundation announced that it has awarded $250,000 in grant funding to 13 wildlife rehabilitation centers across the United States...
PALO ALTO, Calif. — Frazier Life Sciences, an investment firm focused on innovative therapeutics, has appointed Charles (Charlie) Fuchs, M.D., M.P.H., as Senior Advisor.
Dr....
SOUTH SAN FRANCISCO, Calif. — insitro, an AI-driven therapeutics company focused on causal biology, has appointed Joe Hand as chief people officer, tasking him...
Recent Comments